Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "NAGI"

1593 News Found

Biosynthetic Technologies raises $7.5 million
News | February 08, 2022

Biosynthetic Technologies raises $7.5 million

Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.


Rahul Guha to join Thyrocare Technologies as MD & CEO
People | February 07, 2022

Rahul Guha to join Thyrocare Technologies as MD & CEO

Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice


Lupin Q3FY22 PAT at Rs 545.52 cr.
News | February 04, 2022

Lupin Q3FY22 PAT at Rs 545.52 cr.

Lupin has reported consolidated financial results for the period ended December 31, 2021


AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
Healthcare | February 04, 2022

AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day

It has signed an MoU with Plan India to expand its reach to Karnataka


Mylab launches CoviSwift for Covid-19 Point of Care testing
Medical Device | February 03, 2022

Mylab launches CoviSwift for Covid-19 Point of Care testing

Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals


Dr. Reddy’s impresses on sustainability and gender equality again
Sustainability | February 03, 2022

Dr. Reddy’s impresses on sustainability and gender equality again

Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row


Dr. Reddy's set to acquire Nimbus Health
News | February 03, 2022

Dr. Reddy's set to acquire Nimbus Health

The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients


Windlas Biotech concludes SAHPRA audit with an all-clear sign
News | February 02, 2022

Windlas Biotech concludes SAHPRA audit with an all-clear sign

It will enable the company to branch out to new geographies and strengthen its presence in South Africa


Budget 22-23: Healthcare sector applauds focus on mental health
News | February 01, 2022

Budget 22-23: Healthcare sector applauds focus on mental health

A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook


Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.
News | January 31, 2022

Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.

Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021